Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for GABAPENTIN ENACARBIL
- An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users
- Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
- Effect of Gabapentin Enacarbil on Opioid Consumption and Pain Scores
- Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
- The Effect of Horizant (Gabapentin Enacarbil) on Augmentation
- An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
- A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
- ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825
- ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis
- An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
- Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs Syndrome
- HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder
- Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
- Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment
- Specified Drug Use-Results Survey of Regnite
- Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study
- A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers
- Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine
- Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects
- Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome
- Relative Bioavailability Study for GSK1838262 (Gabapentin Enacarbil)
- Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance
- A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)
- A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)
- A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment
- XP13512 vs. Placebo in Patients With Restless Legs Syndrome.
- XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.
- Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.
Clinical trials list
click for details